Fractyl Health announced a first-in-human trial for RJVA-001, targeting T2D and obesity, pending regulatory approval by 2026. Fractyl Health, Inc. has announced the submission of the first module of ...
The transformative impact of artificial intelligence (AI) on clinical research, diagnosis, treatment, and our overall understanding of medicine continues to expand. This collection of in-depth ...
To apply for Clinical Practice, you must complete the following: Submit your application one semester prior to the Clinical Practice Semester. The application period will be the first three weeks of ...
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing ...
A panelist discusses how the injectable combination of cabotegravir and rilpivirine performed well in the real-world OPERA cohort, with over 95% of patients maintaining virologic suppression. However, ...
Wave Life Sciences announced WVE-007, an siRNA treatment for obesity aimed at silencing INHBE to promote sustainable weight loss. Wave Life Sciences has announced the submission of a clinical trial ...
A comprehensive search was conducted in PubMed, Web of Science, and OpenAlex for literature published between December 1, 2022, and December 31, 2024. Studies were included if they explicitly ...
LabConnect, a global provider of central laboratory services and functional service provider solutions for clinical trials, today announced the launch of SampleGISTICS ® 2.0, an application that ...
The use of herbal medicines is one of the oldest health practices, typically involving plants, fungi, their metabolites, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results